Sunshine Biopharma Inc. (SBFM) › Cash & EquivalentsSunshine Biopharma Inc. (SBFM) — Cash & EquivalentsAnnual figures by fiscal year, from SEC filings.2010: $162.4K2011: $60.7K2012: $132.6K2013: $31.2K2014: $143.4K2015: $50.8K2016: $57.5K2017: $107.5K2018: $110.5K2019: $40.5K2020: $989.9K2021: $2.05M2022: $21.83M$21.83M2010Cash & Equivalents (USD)2022Fiscal YearCash & EquivalentsChange YoY2022$21.83M+967.2%2021$2.05M+106.6%2020$989.9K+2344.1%2019$40.5K-63.4%2018$110.5K+2.8%2017$107.5K+87.2%2016$57.5K+13.1%2015$50.8K-64.6%2014$143.4K+359.1%2013$31.2K-76.4%2012$132.6K+118.5%2011$60.7K-62.6%2010$162.4K—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share